Alzheimer's Disease Trial, Not Yet Recruiting NCT07692542 Sponsor: Anhui Medical University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07692542
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Alzheimer's disease using a standard set of medical guidelines (known as the 2011 NIA-AA criteria).
  • People whose memory and thinking abilities fall within a specific range, as measured by a standard test called the Mini-Mental State Examination (MMSE), with a score between 10 and 24.
  • People whose level of dementia falls within a specific range, as measured by a standard scale called the Clinical Dementia Rating (CDR), with a score between 0.5 and 2.
  • People who score 4 or higher on a standard assessment that measures behavioural and psychological symptoms associated with dementia (called the Neuropsychiatric Inventory or NPI).
  • People who have completed at least 5 years of education, or who are able to complete the required memory and thinking tests involved in the study.
  • People who are aged 50 or older and are right-handed.
  • People who have been taking dementia medications (specifically an NMDA receptor antagonist and/or cholinesterase inhibitors) at a stable dose for at least one month before the treatment phase of the trial begins.
  • People whose patient and family member or legal representative are able to understand what the study involves and agree in writing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have received a type of brain stimulation treatment called rTMS in the past 3 months.
  • People who have depression or other mental health conditions.
  • People who have a history of head injury, stroke, epilepsy, or other neurological (brain or nervous system) conditions.
  • People who have structural brain abnormalities visible on certain types of brain scan (T1 or T2 MRI images).
  • People who have a history of unexplained loss of consciousness.
  • People who have an implanted medical device such as a pacemaker, medication pump, vagal stimulator, deep brain stimulator, or any other implanted device that cannot safely be used with MRI scanning.
  • People who have a family history of epilepsy that has not responded to medication.
  • People who have a history of substance abuse within the last 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-0551-62922263

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Anhui Medical University
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Neuropsychiatric Inventory (NPI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov